Product Overview
The VME1 (SARS-CoV-2) Peptide Pool is a lyophilized mixture of 53 peptides from VME1 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). The pool includes 66 peptides derived from a peptide scan (15mers with 11 aa overlap) through amino acids 1-222 on VME1 of SARS-CoV-2 for T cell assays.
Applications
Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion, Cellular immune response
Source
Severe Acute Respiratory Syndrome-related coronavirus 2 (SARS-CoV-2)
Recommended Use
The peptide pool is recommended to use for in-vitro T cell expansion, stimulation of antigen-specific T cells in T cell assays such as ELISpot, cytokine staining, cell-mediated cytotoxicity or proliferation assays.
Area of Interest
Immunology
Limitation
Restrictions for research use only. Intended for use by laboratory professionals.
Datasheet